Music Licensing, Inc. (OTC: SONG) Announces Additional Royalty Payment from Listerine® Intellectual Property Stake, $36 Million to $250 Million Acquisition Targets for 2025, and Strategic Investor Relations Initiatives
Rhea-AI Summary
Music Licensing, Inc. (OTC: SONG) has received another royalty payment from its Listerine® Antiseptic Mouthwash intellectual property stake. The company announced acquisition targets of $36 million to $250 million for 2025, to be funded by Jake P. Noch Family Office, The acquisitions will occur in tranches from $25,000 to several million USD, following the receipt of approximately $24 million in reimbursements under a court-approved 3(a)(10) arrangement. The company plans to enhance investor relations through sponsored research reports, conference participation, and investor outreach. Additionally, Music Licensing is reviewing its Pro Music Rights subsidiary's business model for potential restructuring in 2025.
Positive
- Received new royalty payment from Listerine® intellectual property stake
- Planned acquisitions ranging from $36M to $250M for 2025
- Structured acquisition approach in multiple tranches to minimize risk
- Expected $24M in reimbursements through court-approved arrangement
Negative
- Family Office funding structure restricts direct cash payments to company
- Acquisition funding dependent on successful block trade executions
- Potential restructuring of Pro Music Rights subsidiary indicates operational challenges
News Market Reaction – SONG
On the day this news was published, SONG gained 5.26%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Naples, FL, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG) (“the Company”) is pleased to announce the receipt of another royalty payment from its intellectual property stake in Listerine® Antiseptic Mouthwash. This payment highlights the strength of the Company’s royalty-generating assets and supports its ambitious plans for strategic growth in 2025.
The Company has set acquisition targets ranging from
The acquisitions will occur in tranches ranging from
“Our ongoing royalty payments from the Listerine® stake demonstrate the reliability of our intellectual property investment strategy,” said Jake P. Noch, CEO of Music Licensing, Inc. “Through a compliant funding structure and a disciplined acquisition strategy, we are focused on building a robust and diversified portfolio to enhance shareholder value.”
Jake P. Noch Family Office, LLC plans to commence funding for these acquisitions once it realizes approximately
In addition to its acquisition and funding strategies, Music Licensing, Inc. is taking steps to enhance its investor relations outreach in the coming months. These initiatives include:
- Engaging in sponsored research reports and sponsored analyst coverage to increase visibility among investors.
- Participating in investor conferences to showcase the Company’s strategy and performance to institutional and retail investors.
- Conducting additional regulatory-permitted investor targeting outreach to improve engagement and communication with the investment community.
“As we grow, we recognize the importance of keeping our investors informed and engaged,” added Noch. “By stepping up our investor relations efforts, we aim to ensure that the market has a clear understanding of our strategy, performance, and potential. These initiatives are a vital part of our commitment to transparency and shareholder value creation.”
The Company is also actively reviewing the business model of its wholly owned subsidiary, Pro Music Rights. In 2025, Music Licensing, Inc. may consider restructuring Pro Music Rights to improve operational efficiency and align with evolving market dynamics, further strengthening its position in the intellectual property sector.
“Pro Music Rights has been a cornerstone of our portfolio, and we are committed to ensuring its continued success,” said Noch. “By evaluating its current business model, we aim to identify opportunities to optimize its operations and maximize its contribution to our overall growth.”
Music Licensing, Inc. remains dedicated to providing regular updates on its acquisition strategy, investor relations efforts, and strategic initiatives as part of its ongoing commitment to transparency and shareholder engagement.
About Music Licensing, Inc. (OTC: SONG) (ProMusicRights.com)
Music Licensing, Inc. (OTC: SONG), also known as Pro Music Rights, is a diversified holding company and the fifth public performance rights organization (PRO) formed in the United States. Its licensees include notable companies such as TikTok, iHeart Media, Triller, Napster, 7Digital, Vevo, and many others. Pro Music Rights holds an estimated market share of
Additionally, Music Licensing, Inc. (OTC: SONG) owns royalty stakes in Listerine "Mouthwash" Antiseptic and musical works by artists such as The Weeknd, Justin Bieber, Kanye West, Elton John, Mike Posner, blackbear, Lil Nas X, Lil Yachty, DaBaby, Stunna 4 Vegas, Miley Cyrus, Lil Wayne, XXXTentacion, Jeremih, Ty Dolla $ign, Eric Bellinger, Ne-Yo, MoneyBagg Yo, Halsey, Desiigner, DaniLeigh, Rihanna, and numerous others.
Forward-Looking Statements:
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Music Licensing, Inc. & Pro Music Rights, Inc. to accomplish its stated plan of business. Music Licensing, Inc. & Pro Music Rights, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by Pro Music Rights, Inc., Music Licensing, Inc., or any other person.
Non-Legal Advice Disclosure:
This press release does not constitute legal advice, and readers are advised to seek legal counsel for any legal matters or questions related to the content herein.
Non-Investment Advice Disclosure:
This communication is intended solely for informational purposes and does not in any way imply or constitute a recommendation or solicitation for the purchase or sale of any securities, commodities, bonds, options, derivatives, or any other investment products. Any decisions related to investments should be made after thorough research and consultation with a qualified financial advisor or professional. We assume no liability for any actions taken or not taken based on the information provided in this communication.
Contact: investors@ProMusicRights.com
SOURCE: Music Licensing, Inc
FAQ
What are Music Licensing Inc.'s (SONG) acquisition targets for 2025?
How will SONG fund its 2025 acquisitions?
What is SONG's latest development with Listerine royalties?
What investor relations initiatives is SONG planning?
